Review of the FTSE Med Index
 |
|
|
Thursday, November 13, 2014 |
|
|
REVIEW OF THE FTSE MED INDEX |
|
The Advisory Committee of the Common Regional Index FTSE Med Index carried out a detailed review on the index's performance for the half-year period from April 2014 until October 2014, according to the Ground Rules.
During the current review, and according to the Ground Rules, there were two (2) additions, two (2) deletions and zero (0) investability weight change of current index constituents.
In detail the changes are:
| Additions | ||
| Compugen Ltd | Israel | 97% |
| Nova Measuring Instruments Ltd | Israel | 100% |
| Deletions | ||
| Kamada | Israel | Rebalance Deletion |
| Gr. Sarantis S.A. | Greece | Auto Deletion |
| Reserve List | ||
| Silicom Ltd | Israel | 77% |
| Elco | Israel | 16% |
| Gilat Satellite Networks | Israel | 96% |
| AudioCodes Ltd | Israel | 75% |
| Plaisio Computers S.A. | Greece | 18% |